Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dyadic International, Inc. - Common Stock (NQ:DYAI)

0.7048 -0.1652 (-18.99%)
Streaming Delayed Price Updated: 2:46 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dyadic International, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Dyadic (DYAI) Q4 2025 Earnings Call Transcript ↗
Dyadic (DYAI) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Dyadic International Inc (NASDAQ:DYAI) Reports Q4 2025 Earnings Miss, Stock Dips ↗
Via Chartmill
Topics Earnings
News headline image
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
A Look at Dyadic International's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Santa’s Rally: CMCT, SURG, SIDU, MYSE, AZI – Stocks Under $5 to Watch Now – More Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
Via ACCESS Newswire
News headline image
What's going on in today's after hours session ↗
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
Via ACCESS Newswire
News headline image
Top movers in Monday's pre-market session ↗
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic (DYAI) Q3 2025 Earnings Call Transcript ↗
Dyadic (DYAI) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Dyadic to Present at Investor Conferences and BPI East
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic International Narrows Q2 Loss ↗
Via The Motley Fool
News headline image
Dyadic (DYAI) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Dyadic Revenue Jumps 150% in Fiscal Q2 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Dyadic International Inc (NASDAQ:DYAI) Reports Mixed Q2 2025 Earnings Amid Strategic Rebranding ↗
Dyadic International (DYAI) reported mixed Q2 2025 results, beating revenue estimates but posting an EPS loss. Shares dipped as investors weigh its rebranding and shift to commercial operations. 
Via Chartmill
News headline image
Earnings Scheduled For August 13, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.